Psycho- and neuro-pharmacology. Amsterdam: Elsevier, 1983: 163–80 Google Scholar Baldessarini RJ. Drugs and the treatment of psychiatric disorders. In: Gilman AG, Goodman LS, Rail TW, et al., editors. Goodman and Gilman’s the pharmacological basis of therapeutics. New York: MacMillan, ...
CNS safety pharmacology (including drug dependency)Accidental poisoningIllegal spiritAtropa BelladonnaMulticolumn HPLC/UV systemTLCPanaxydol, a polyacetylene compound isolated from Panaxginseng, exerts anti-proliferative effects against malignant cells. No previous study, however, has been reported on its ...
In total, 44 RCTs with 3935 participants were included. Trazodone did not significantly impact subjective total sleep time (TST) [WMD = 0.73 min, 95% confidence interval (CI) − 24.62; 26.07,p = 0.96] but improved sleep quality (SQ) (SMD = − 0.58, 95% CI −...
British Journal of Clinical Pharmacology Volume 54, Issue 4, pages 344–348, October 2002Additional Information How to Cite Shaikh, S. and Kerwin, R. W. (2002), Receptor pharmacogenetics: relevance to CNS syndromes. British Journal of Clinical Pharmacology, 54: 344–348. doi: 10.1046/j.1365...
Biochemical Pharmacology Volume 151, May 2018, Pages 291-306ReviewRegulatory-accepted drug development tools are needed to accelerate innovative CNS disease treatments Author links open overlay panelStephen P. Arnerić a, Volker D. Kern a, Diane T. Stephenson bShow more Add to Mendeley Share ...
European Journal of Clinical Pharmacology (2021) Effects of Ketamine and Midazolam on Simultaneous EEG/fMRI Data During Working Memory Processes Anna E. M. Forsyth Rebecca McMillan Suresh D. Muthukumaraswamy Brain Topography (2021) Comparison of local spectral modulation, and temporal correlation, of...
Drug-induced epigenetic changes produce drug tolerance. PLoS Biol 5: e265. Wedlund PJ (2000). The CYP2C19 enzyme polymorphism. Pharmacology 6: 174–185. Wedlund PJ, de Leon J (2001). Pharmacogenetic testing: the cost factor. Pharmacogenomics J 1: 171–174. Weinshilboum R, Wang L (2004)...
CNS Neuroscience & Therapeutics provides a medium for rapid publication of original clinical, experimental, and translational research papers, timely reviews and reports of novel findings of therapeutic relevance to the central nervous system, as well as papers related to clinical pharmacology, drug devel...
Drug Interactions Paroxetine inhibits CYP2D6 and thus has the potential to interact with other drugs that are metabolised by the enzyme. In addition, drugs that affect hepatic metabolism may alter the metabolism and pharmacokinetics of paroxetine. As paroxetine is highly protein bound, it may displac...
The Journal of Pharmacology and Experimental Therapeutics. vol. 303, No. 1. Pöllmann et al. CNS Drugs. 2000 22(4) 291-324. Paul Gilbert, The Unknown Disease: Multiple Sclerosis, 2007. Rashid et al. The Journal of Pharmacology and Experimental Therapeutics. vol. 303, No. 1, 2002....